Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension

被引:14
作者
Maeda, Nair Y. [1 ]
Carvalho, Joao H. [1 ]
Otake, Andreia H.
Mesquita, Sonia M. F. [2 ]
Bydlowski, Sergio P.
Lopes, Antonio Augusto [2 ]
机构
[1] Univ Sao Paulo, Sch Med, Pro Sangue Fdn, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Pulmonary hypertension; Platelet activation; Platelets protease activated receptors; Thrombin receptors; P-selectin; Thrombosis; THROMBIN RECEPTORS; INHIBITION; AGGREGATION; APROTININ; DISEASE; LIGAND; PAR4;
D O I
10.1016/j.thromres.2009.04.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pulmonary arterial hypertension (PAH) is frequently associated with thrombotic events, particularly involving the pulmonary microcirculation at sites of vascular injury. We therefore decided to analyse protease-activated receptor 1 (PAR1), a key element in the activation of human platelets by thrombin, in PAH patients in stable clinical condition. Methods: Using flow cytometry, we analyzed platelet PAR1 density, PAR1-mediated exposure of P-selectin and the formation of platelet-leukocyte aggregates in 30 PAH patients aged 11 to 78 years (median 50.5 years). The control group consisted of 25 healthy subjects with the same age range as patients. Results: In patients, total platelet PAR1 density and uncleaved PAR1 density correlated negatively with platelet count (r(2) = 0.33 and r(2) = 0.34 respectively, p < 0.0015). In patients with a low platelet count (<150 x 10(9) platelets/L), both densities were increased relative to controls (82% and 33% respectively, p < 0.05). Thrombin peptide-induced platelet exposure of P-selectin was directly related to total and uncleaved PAR1 density (respectively, r(2) = 0.33 and r(2) = 0.29, p < 0.0025) and increased in subjects with low platelet count (46% versus those with normal platelet count, p < 0.05). Patients with low platelet count had decreased in vitro thrombin-induced formation of platelet-leukocyte aggregates (57% decrease versus controls, p < 0.05). Conclusions: There seems to be a subpopulation of PAH patients with increased propensity to thrombotic events as suggested by increased platelet PAR1 expression and PAR-mediated surface exposure of P-selectin associated with decreased platelet count. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 29 条
[1]   Development of potent thrombin receptor antagonist peptides [J].
Bernatowicz, MS ;
Klimas, CE ;
Hartl, KS ;
Peluso, M ;
Allegretto, NJ ;
Seiler, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4879-4887
[2]   Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents [J].
Chackalamannil, S ;
Xia, Y ;
Greenlee, WJ ;
Clasby, M ;
Doller, D ;
Tsai, H ;
Asberom, T ;
Czarniecki, M ;
Ahn, HS ;
Boykow, G ;
Foster, C ;
Agans-Fantuzzi, J ;
Bryant, M ;
Lau, J ;
Chintala, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) :5884-5887
[3]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[4]   Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets [J].
Covic, L ;
Gresser, AL ;
Kuliopulos, A .
BIOCHEMISTRY, 2000, 39 (18) :5458-5467
[5]   Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides [J].
Covic, L ;
Gresser, AL ;
Talavera, J ;
Swift, S ;
Kuliopulos, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :643-648
[6]   Soluble CD40 ligand in pulmonary arterial hypertension -: Possible pathogenic role of the interaction between platelets and endothelial cells [J].
Damås, JK ;
Otterdal, K ;
Yndestad, A ;
Aass, H ;
Solum, NO ;
Froland, SS ;
Simonsen, S ;
Aukrust, P ;
Andreassen, AK .
CIRCULATION, 2004, 110 (08) :999-1005
[7]   Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery [J].
Day, JRS ;
Punjabi, PP ;
Randi, AM ;
Haskard, DO ;
Landis, RC ;
Taylor, KM .
CIRCULATION, 2004, 110 (17) :2597-2600
[8]   Circulating platelet-leukocyte aggregates: A marker of microvascular injury in diabetic patients [J].
Etalamy, I. ;
Chakroun, T. ;
Gerotziafas, G. T. ;
Petropoulou, A. ;
Robert, F. ;
Karroum, A. ;
Elgrably, F. ;
Samama, M. -M. ;
Hatmi, M. .
THROMBOSIS RESEARCH, 2008, 121 (06) :843-848
[9]   Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease [J].
Furman, MI ;
Benoit, SE ;
Barnard, MR ;
Valeri, CR ;
Borbone, ML ;
Becker, RC ;
Hechtman, HB ;
Michelson, AD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :352-358
[10]   PRIMARY PULMONARY-HYPERTENSION - NATURAL-HISTORY AND THE IMPORTANCE OF THROMBOSIS [J].
FUSTER, V ;
STEELE, PM ;
EDWARDS, WD ;
GERSH, BJ ;
MCGOON, MD ;
FRYE, RL .
CIRCULATION, 1984, 70 (04) :580-587